Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Change in Intangibles: 2018-2020

  • Collegium Pharmaceutical's Change in Intangibles was N/A to $1.4 million in Q2 2020 from the same period last year, while for Jun 2020 it was $387.1 million, marking a year-over-year change of. This contributed to the annual value of $368.2 million for FY2020, which is N/A change from last year.
  • Per Collegium Pharmaceutical's latest filing, its Change in Intangibles stood at $1.4 million for Q2 2020, which was down 99.61% from $366.8 million recorded in Q1 2020.
  • In the past 5 years, Collegium Pharmaceutical's Change in Intangibles registered a high of $366.8 million during Q1 2020, and its lowest value of $116,000 during Q2 2018.
  • Its 2-year average for Change in Intangibles is $96.8 million, with a median of $10.1 million in 2018.